Purchase Order 12905B21P0008
- Not listed
- The U.S. Department of Agriculture's Agricultural Research Service Pacific West Area awarded a $10,370 firm fixed-price purchase order to Metabiologics, Inc. on May 22, 2017, for the supply of botulinum neurotoxin type A complex, botulinum neurotoxin type E holotoxin, and rabbit polyclonal antibodies. The contract, which was not set aside for small businesses, was completed by June 7, 2017, and represents a continuation of the agency's routine procurement of highly purified botulinum toxin for...
- The U.S. Department of Agriculture's Agricultural Research Service Pacific West Area awarded a $11,000 firm fixed-price purchase order to Metabiologics, Inc. for the supply of botulinum neurotoxin. The contract was issued on June 30, 2021, with an ultimate completion date of July 30, 2021, and carries no set-aside designation. Metabiologics, a for-profit manufacturer registered with the federal government since 2001, serves as the prime contractor and will perform the work in Albany, California....
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred sixteen thousand four hundred twenty-six dollars to Amerisourcebergen Drug Corporation for 200 unit vials of botulinum toxin type A. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products under contract number 4561674991 to a location in Conshohocken, Pennsylvania by August 21, 2023. The Defense Logistics Agency facilitates supply chain management...
- This is a $6,821,012.21 Cost Plus Fixed Fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The contract is for the development of a broad spectrum monoclonal antibody-based therapeutic for botulism, a biological threat. The contract has no set-aside designation and the ultimate completion date is September...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $35,995.44 contract is for the delivery of Botulinum Toxin Type A, a pharmaceutical product, to support the medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued up to...
- This is a cost-plus-fixed-fee delivery order contract awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The $1,660,449.00 contract is for the characterization of a non-paralyzing botulinum neurotoxin (BoNT)-based biopharmaceutical for the treatment of neuropathic pain. The work will involve conducting nonclinical...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 5, 2026, with a ceiling value of $15,355.84 for botulinum toxin type A 1S, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The order is issued under the company's single-award IDC with DLA, which carries a ceiling value of $499,999,999 and an ultimate completion date of...
- The Defense Logistics Agency issued a firm fixed-price delivery order valued at $13,916.23 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botulinum Toxin Type A 1S. The award, issued on February 3, 2026, with an ultimate completion date of February 19, 2026, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order is issued under DMS...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $34,611 firm fixed-price delivery order contract is for the provision of Botulinum Toxin Type A. This award is associated with a larger indefinite delivery vehicle (IDV) contract #SPE2DB, valued up to $4,999,999 through 2025, which enables DLA to issue delivery orders for a wide range of pharmaceutical items to support military medical...
- The Defense Logistics Agency Troop Support Medical awarded a $61,123.65 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 unit vials of botulinum toxin type A (BOTOX). The contract has a period of performance from August 3, 2023 through August 24, 2023, with all work to be performed by the prime contractor in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. This delivery order was issued against an existing...
The U.S. Department of Agriculture's Agricultural Research Service awarded a purchase order to Metabiologics, Inc. for the procurement of 200 micrograms of botulinum neurotoxin type F holotoxin in 100-microgram units. The contract, valued at $10,950.00 with a firm fixed price arrangement, was awarded on October 31, 2020, with completion required by November 30, 2020. Performance is based in Madison, Wisconsin. This procurement was not designated as a set-aside contract. Metabiologics is a subsidiary of Object Pharma Inc., a self-certified small disadvantaged business and veteran-owned enterprise registered with the federal government. The Agricultural Research Service has maintained an ongoing relationship with Metabiologics since 2019 for acquiring highly purified botulinum toxin research quantities. This award represents a continuation of that partnership, consistent with the contractor's established role as a primary supplier of various botulinum neurotoxin serotypes to the Pacific West Area office. The specialized nature of this procurement—involving a specific toxin type and precise quantity for research purposes—aligns with the Agricultural Research Service's biotechnology and pathogen research initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 10/31/20 |